• Explore /
  • Poster
  • / Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hormone-responsive (HR) breast cancer: The FATA-GIM3 trial.

Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hormone-responsive (HR) breast cancer: The FATA-GIM3 trial.

Abstract Poster

Authors

null

Francesco Perrone

Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”- IRCCS, Naples, Italy

Francesco Perrone , Ciro Gallo , Michele De Laurentiis , Giancarlo Bisagni , Grazia Arpino , Maria Giuseppa Sarobba , Ferdinando Riccardi , Antonio Russo , Lucia Del Mastro , Alessio Aligi Cogoni , Francesco Cognetti , Stefania Gori , Antonio Frassoldati , Domenico Amoroso , Lucio Laudadio , Luca Moscetti , Filippo Montemurro , Francesco Nuzzo , Paolo Carlini , Sabino De Placido

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT00541086

Citation

J Clin Oncol 35, 2017 (suppl; abstr 515)

DOI

10.1200/JCO.2017.35.15_suppl.515

Abstract #

515

Poster Bd #

115

Abstract Disclosures

Similar Posters

First Author: Mario Campone

First Author: Charles Geyer

First Author: Maria Vittoria Dieci

First Author: Hao Liao